Whereas dihydropyridine CBBs presented a lower risk of stroke, non-dihydropyridine CCBs did not achieve significance.
← all excerpts
Clinical Experience with Diltiazem in the Treatment of Cardiovascular Diseases.
1
—
—
Whereas dihydropyridine CBBs presented a lower risk of stroke, non-dihydropyridine CCBs did not achieve significance.